A5022946988- Growth Hormone and Insulin-like Growth Factors
- Pituitary Gland Disorders and Treatments
- Bone health and osteoporosis research
- Effects and risks of endocrine disrupting chemicals
- Liver Disease Diagnosis and Treatment
- Diet and metabolism studies
- Adrenal Hormones and Disorders
- Vitamin D Research Studies
- Bone health and treatments
- Adrenal and Paraganglionic Tumors
- Diet, Metabolism, and Disease
- Childhood Cancer Survivors' Quality of Life
- Lipid metabolism and disorders
- Parathyroid Disorders and Treatments
- Celiac Disease Research and Management
- Metabolomics and Mass Spectrometry Studies
- Diabetes and associated disorders
- Genetic Syndromes and Imprinting
- Nutritional Studies and Diet
- Hormonal Regulation and Hypertension
- Metabolism and Genetic Disorders
- Liver Disease and Transplantation
- Thyroid Disorders and Treatments
- Folate and B Vitamins Research
- Ovarian function and disorders
University of Novi Sad
2016-2025
Klinički centar Vojvodine
2016-2025
Comenius University Bratislava
2020
Diabetes Australia
2017
Magna Graecia University
2016
The diagnosis of adult GH deficiency (AGHD) is challenging and often requires confirmation with a stimulation test (GHST). insulin tolerance (ITT) considered the reference standard GHST but labor intensive, can cause severe hypoglycemia, contraindicated for certain patients. Macimorelin, an orally active secretagogue, could be used to diagnose AGHD by measuring stimulated levels after oral dose. present multicenter, open-label, randomized, two-way crossover trial was designed validate...
OBJECTIVE: It has recently been shown that increased body weight is associated with prolactinomas and loss occurs normalization of prolactin levels. On the other hand, decreased dopaminergic tone in humans well correlated obesity. The objective this study was to correlate changes levels leptin mass index (BMI) patients treated long-acting dopamine agonist bromocriptine (BC). METHODS: Eleven female twelve male patients, aged 36.7+/-2.6 years BMI males 30.4+/-1.7 kg/m(2) females 24.4+/-1.2...
The liver is involved in the metabolism of vitamin D. prevalence osteopenia alcoholic disease (ALD) patients 34-48%, and osteoporosis 11-36%. Advanced considered a risk factor for development osteoporosis. aim this study was to establish relationship between D level Child-Pugh score with cirrhosis (ALC), evaluate effects oral supplementation.Seventy male ALC absence active alcohol intake were enrolled their clinical laboratory data recorded. A supplementation cholecalciferol 1000 IU/day...
Scope Nonalcoholic fatty liver disease (NAFLD) is the most common with poor therapeutic strategies. Mastiha possesses antioxidant/anti‐inflammatory and lipid‐lowering properties. The authors investigate effectiveness of as a nonpharmacological intervention in NAFLD. Methods Results Ninety‐eight patients NAFLD three countries (Greece, Italy, Serbia) are randomly allocated to either or Placebo for 6 months, part multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group clinical...
The objective of the study was to asses possible influence hypothalamo-pituitary deficiencies, and growth hormone (GH) deficiency in particular, on cognition adult patients with traumatic brain injury (TBI). TBI is a recently identified risk factor for cognitive deficits hypopituitarism. Even favorable outcome after may present persistent bodily, psychosocial, impairments, resembling untreated partial or complete pituitary insufficiency.We performed retrospective cross-sectional endocrine...
Non-alcoholic fatty liver disease (NAFLD) is the most common with no therapeutic consensus. Oxidation and inflammation are hallmarks in progression of this complex disease, which also involves interactions between genetic background environment. Mastiha a natural nutritional supplement known to possess antioxidant anti-inflammatory properties. This study investigated how 6-month supplementation (2.1 g/day) could impact inflammatory status patients NAFLD, whether variants significantly...
Guidelines recommend adults with pituitary disease in whom GH therapy is contemplated, to be tested for deficiency (AGHD); however, clinical practice not uniform. Aims (1) To record current of AGHD management throughout Europe and benchmark it against guidelines; (2) evaluate educational status healthcare professionals about AGHD. Design Online survey endocrine centres Europe. Patients methods Endocrinologists voluntarily completed an electronic questionnaire regarding patients diagnosed or...
Background/Aim. Through its various activities, World Health Organization (WHO) contributed to increasing the understanding of concept quality life. People with diabetes have a lower life than people without chronic illnesses. The aim this study was examine differences in life, related health, patients mellitus (DM) type 2 by age, gender and therapy. Methods. We performed cross-sectional at outpatient department Clinical Center Novi Sad Ruma - General Practice. group consisted 90 DM 2, 41...
Pituitary xanthogranulomatomas (XG) are a rare pathological entity caused by accumulation of lipid laden macrophages and reactive granuloma formation usually triggered cystic fluid leakage or hemorrhage. Our aim was to compare clinical characteristics presenting features patients with secondary etiology XG those no identifiable founding lesion (primary -"pure" XG) in order gain new insights into this pituitary pathology. In retrospective review 714 operated for sellar masses, at tertiary...